药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Ioversol
Canagliflozin may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Iothalamic acid
Canagliflozin may increase the excretion rate of Iothalamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Gadoteric acid
Canagliflozin may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Chromic chloride
Canagliflozin may increase the excretion rate of Chromic chloride which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Aurothioglucose
Canagliflozin may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Pentastarch
Canagliflozin may increase the excretion rate of Pentastarch which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Hydroxyethyl Starch
Canagliflozin may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Magnesium hydroxide
Canagliflozin may increase the excretion rate of Magnesium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Ancestim
Canagliflozin may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Vilanterol
Canagliflozin may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Idebenone
Canagliflozin may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Tasimelteon
Canagliflozin may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Vortioxetine
Canagliflozin may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Corifollitropin alfa
Canagliflozin may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Ceftolozane
Canagliflozin may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Macitentan
Canagliflozin may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Trametinib
Canagliflozin may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Glycerol phenylbutyrate
Canagliflozin may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Formestane
Formestane may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Teduglutide
Teduglutide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.